LSD1 inhibition: a therapeutic strategy in cancer?
- 8 September 2012
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Targets
- Vol. 16 (12) , 1239-1249
Abstract
Introduction: The role of epigenetic dysfunction in cancer is increasingly appreciated. This has raised the question as to whether enzymes that regulate the structure and function of chromatin might represent novel therapeutic targets. The histone demethylase LSD1 is one such candidate and novel, potent inhibitors are under development. Areas covered: The literature on LSD1 (also known as KDM1A, AOF2, BHC110 or KIAA0601) was identified in Pubmed and is herein discussed. Areas covered include the structure and enzymatic activity of LSD1, its role in chromatin regulatory complexes, its functional roles in normal and malignant tissue, pharmacological inhibitors of its activity and their putative therapeutic roles. Expert opinion: Pre-clinical data supporting a therapeutic role for LSD1 inhibitors are most encouraging in acute myeloid leukaemia, although optimal dosing strategies and beneficial combinations with other agents remain unclear. Studies making use of potent, selective LSD1 inhibitors active in the nanomolar range are required to establish therapeutic indications in other subtypes of haematological malignancy, and in solid tumours.Keywords
This publication has 87 references indexed in Scilit:
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1LCancer Cell, 2011
- LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast CancerCell, 2009
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III studyThe Lancet Oncology, 2009
- Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemiaGenes & Development, 2008
- Crystal structure of human histone lysine-specific demethylase 1 (LSD1)Proceedings of the National Academy of Sciences, 2006
- Crystal structure and mechanism of human lysine-specific demethylase-1Nature Structural & Molecular Biology, 2006
- Histone demethylation by a family of JmjC domain-containing proteinsNature, 2005
- Regulation of LSD1 Histone Demethylase Activity by Its Associated FactorsMolecular Cell, 2005
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004
- A Candidate X-linked Mental Retardation Gene Is a Component of a New Family of Histone Deacetylase-containing ComplexesJournal of Biological Chemistry, 2003